Hu Y - Search Results

1

In Vivo Quantitative Understanding of PEGylated Liposome's Influence on Brain Delivery of Diphenhydramine.

Hu Y, Gaillard PJ, Rip J, de Lange ECM, Hammarlund-Udenaes M. Hu Y, et al. Mol Pharm. 2018 Dec 3;15(12):5493-5500. doi: 10.1021/acs.molpharmaceut.8b00611. Epub 2018 Nov 8. Mol Pharm. 2018. PMID: 30376346

2

The Impact of Liposomal Formulations on the Release and Brain Delivery of Methotrexate: An In Vivo Microdialysis Study.

Hu Y, Rip J, Gaillard PJ, de Lange ECM, Hammarlund-Udenaes M. Hu Y, et al. J Pharm Sci. 2017 Sep;106(9):2606-2613. doi: 10.1016/j.xphs.2017.03.009. Epub 2017 Mar 18. J Pharm Sci. 2017. PMID: 28322936

3

Targeted brain delivery of methotrexate by glutathione PEGylated liposomes: How can the formulation make a difference?

Hu Y, Gaillard PJ, de Lange ECM, Hammarlund-Udenaes M. Hu Y, et al. Eur J Pharm Biopharm. 2019 Jun;139:197-204. doi: 10.1016/j.ejpb.2019.04.004. Epub 2019 Apr 2. Eur J Pharm Biopharm. 2019. PMID: 30951819

4

Understanding the Influence of Nanocarrier-Mediated Brain Delivery on Therapeutic Performance Through Pharmacokinetic-Pharmacodynamic Modeling.

Hu Y, Hammarlund-Udenaes M, Fridén M. Hu Y, et al. J Pharm Sci. 2019 Oct;108(10):3425-3433. doi: 10.1016/j.xphs.2019.05.029. Epub 2019 Jun 1. J Pharm Sci. 2019. PMID: 31163187

5

Perspectives on Nanodelivery to the Brain: Prerequisites for Successful Brain Treatment.

Hu Y, Hammarlund-Udenaes M. Hu Y, et al. Mol Pharm. 2020 Nov 2;17(11):4029-4039. doi: 10.1021/acs.molpharmaceut.0c00881. Epub 2020 Oct 16. Mol Pharm. 2020. PMID: 33064009 Free PMC article. Review.

6

Analysis of the contributing role of drug transport across biological barriers in the development and treatment of chemotherapy-induced peripheral neuropathy.

Hu Y, Girdenyté M, Roest L, Liukkonen I, Siskou M, Bällgren F, Hammarlund-Udenaes M, Loryan I. Hu Y, et al. Fluids Barriers CNS. 2024 Feb 8;21(1):13. doi: 10.1186/s12987-024-00519-7. Fluids Barriers CNS. 2024. PMID: 38331886 Free PMC article.

7

Region-independent active CNS net uptake of marketed H⁺/OC antiporter system substrates.

Bällgren F, Hu Y, Li S, van de Beek L, Hammarlund-Udenaes M, Loryan I. Bällgren F, et al. Among authors: hu y. Front Cell Neurosci. 2024 Oct 29;18:1493644. doi: 10.3389/fncel.2024.1493644. eCollection 2024. Front Cell Neurosci. 2024. PMID: 39534684 Free PMC article.

8

Formulation-dependent differences in paclitaxel distribution to anatomical sites relevant to chemotherapy-induced peripheral neuropathy.

Girdenytė M, Hu Y, Ginosyan A, Hammarlund-Udenaes M, Loryan I. Girdenytė M, et al. Among authors: hu y. Front Pharmacol. 2024 Nov 6;15:1486686. doi: 10.3389/fphar.2024.1486686. eCollection 2024. Front Pharmacol. 2024. PMID: 39568585 Free PMC article.

9

Intraocular siRNA Delivery Mediated by Penetratin Derivative to Silence Orthotopic Retinoblastoma Gene.

Gao X, Fan X, Jiang K, Hu Y, Liu Y, Lu W, Wei G. Gao X, et al. Among authors: hu y. Pharmaceutics. 2023 Feb 23;15(3):745. doi: 10.3390/pharmaceutics15030745. Pharmaceutics. 2023. PMID: 36986605 Free PMC article.

10

Molecular basis of mood and cognitive adverse events elucidated via a combination of pharmacovigilance data mining and functional enrichment analysis.

Andronis C, Silva JP, Lekka E, Virvilis V, Carmo H, Bampali K, Ernst M, Hu Y, Loryan I, Richard J, Carvalho F, Savić MM. Andronis C, et al. Among authors: hu y. Arch Toxicol. 2020 Aug;94(8):2829-2845. doi: 10.1007/s00204-020-02788-1. Epub 2020 Jun 5. Arch Toxicol. 2020. PMID: 32504122 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48,043 results

Search Page

Filters